-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA PHARMA ENTERS INTO GLOBAL LICENSE AGREEMENT WITH ABBVIE FOR NXE0033744, A NOVEL EP4 RECEPTOR AGONIST FOR INFLAMMATORY BOWEL DISEASE

Reuters·11/04/2026 08:40:56

Please log in to view news